Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Using general practitioners to recruit individuals with low socioeconomic position to preventive health checks is feasible: a cross sectional study.

Kamstrup-Larsen N, Dalton SO, Broholm-Jørgensen M, Larsen LB, Thomsen JL, Johansen C, Tolstrup JS.

Scand J Prim Health Care. 2019 Jul 9:1-8. doi: 10.1080/02813432.2019.1639901. [Epub ahead of print]

PMID:
31286817
2.

Personality as a predictor of well-being in a randomized trial of a mindfulness-based stress reduction of Danish women with breast cancer.

Jagielski CH, Tucker DC, Dalton SO, Mrug S, Würtzen H, Johansen C.

J Psychosoc Oncol. 2019 Jul 3:1-16. doi: 10.1080/07347332.2019.1626524. [Epub ahead of print]

PMID:
31267818
3.

SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer.

Stranne J, Brasso K, Brennhovd B, Johansson E, Jäderling F, Kouri M, Lilleby W, Meidahl Petersen P, Mirtti T, Pettersson A, Rannikko A, Thellenberg C, Akre O.

Scand J Urol. 2018 Oct - Dec;52(5-6):313-320. doi: 10.1080/21681805.2018.1520295. Epub 2018 Dec 26.

PMID:
30585526
4.

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.

Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DPS, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM.

N Engl J Med. 2018 Feb 22;378(8):731-739. doi: 10.1056/NEJMoa1714448.

5.

Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan.

Toft A, Urup T, Christensen IJ, Michaelsen SR, Lukram B, Grunnet K, Kosteljanetz M, Larsen VA, Lassen U, Broholm H, Poulsen HS.

Cancer Invest. 2018 Feb 7;36(2):165-174. doi: 10.1080/07357907.2018.1430818. Epub 2018 Feb 2. Review.

PMID:
29393706
6.

Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B.

Staberg M, Rasmussen RD, Michaelsen SR, Pedersen H, Jensen KE, Villingshøj M, Skjoth-Rasmussen J, Brennum J, Vitting-Seerup K, Poulsen HS, Hamerlik P.

Mol Oncol. 2018 Mar;12(3):406-420. doi: 10.1002/1878-0261.12174. Epub 2018 Feb 12.

7.

The management and survival outcomes of nasopharyngeal cancer in the Nordic countries<sup/>.

Mäkitie A, Ruuskanen M, Bentzen J, Brun E, Gebre-Medhin M, Friesland S, Marsk E, Hammarstedt-Nordenvall L, Gille E, Reizenstein J, Adell G, Farnebo L, Rzepecki J, Haugen H, Söderström K, Zackrisson B, Bergström S, Lödén B, Cederblad L, Laurell G, Smeland E, Folkvard Evensen J, Lund JÅ, Tøndel H, Karlsdottir Å, Jóhannsson J, Johansen J, Kristensen CA, Jensen K, Andersen LJ, Koivunen P, Korpela M, Voutilainen L, Wigren T, Minn H, Joensuu H, Overgaard J, Saarilahti K.

Acta Oncol. 2018 Apr;57(4):557-560. doi: 10.1080/0284186X.2017.1408961. Epub 2017 Dec 5. No abstract available.

PMID:
29202641
8.

Expression and crystallographic studies of the D1D2 domains of C4.4A, a homologous protein to the urokinase receptor.

Chen S, Lin L, Yuan C, Gårdsvoll H, Kriegbaum MC, Ploug M, Huang M.

Acta Crystallogr F Struct Biol Commun. 2017 Aug 1;73(Pt 8):486-490. doi: 10.1107/S2053230X17009748. Epub 2017 Jul 27.

PMID:
28777093
9.

Incidence of pancreatic cancer in Denmark: 70 years of registration, 1943-2012.

Weble TC, Bjerregaard JK, Kissmeyer P, Vyberg M, Hansen CP, Holländer NH, Johansen C.

Acta Oncol. 2017 Dec;56(12):1763-1768. doi: 10.1080/0284186X.2017.1351036. Epub 2017 Jul 25.

PMID:
28741399
10.

Residential traffic noise exposure and vestibular schwannoma - a Danish case-control study.

Roswall N, Stangerup SE, Cayé-Thomasen P, Schüz J, Johansen C, Jensen SS, Raaschou-Nielsen O, Sørensen M.

Acta Oncol. 2017 Oct;56(10):1310-1316. doi: 10.1080/0284186X.2017.1337925. Epub 2017 Jun 13.

PMID:
28609173
11.

Implementation of lung cancer CT screening in the Nordic countries.

Pedersen JH, Sørensen JB, Saghir Z, Fløtten Ø, Brustugun OT, Ashraf H, Strand TE, Friesland S, Koyi H, Ek L, Nyrén S, Bergman P, Jekunen A, Nieminen EM, Gudbjartsson T.

Acta Oncol. 2017 Oct;56(10):1249-1257. doi: 10.1080/0284186X.2017.1329592. Epub 2017 Jun 1.

PMID:
28571524
12.

Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.

Beigneux AP, Miyashita K, Ploug M, Blom DJ, Ai M, Linton MF, Khovidhunkit W, Dufour R, Garg A, McMahon MA, Pullinger CR, Sandoval NP, Hu X, Allan CM, Larsson M, Machida T, Murakami M, Reue K, Tontonoz P, Goldberg IJ, Moulin P, Charrière S, Fong LG, Nakajima K, Young SG.

N Engl J Med. 2017 Apr 27;376(17):1647-1658. doi: 10.1056/NEJMoa1611930. Epub 2017 Apr 5.

13.

Feasibility and acceptability of active book clubs in cancer survivors - an explorative investigation.

Hammer NM, Egestad LK, Nielsen SG, Bjerre E, Johansen C, Egerod I, Pinto B, Midtgaard J.

Acta Oncol. 2017 Mar;56(3):471-478. doi: 10.1080/0284186X.2016.1277036. Epub 2017 Jan 17.

PMID:
28094664
14.

Visual outcome, endocrine function and tumor control after fractionated stereotactic radiation therapy of craniopharyngiomas in adults: findings in a prospective cohort.

Astradsson A, Munck Af Rosenschöld P, Feldt-Rasmussen U, Poulsgaard L, Wiencke AK, Ohlhues L, Engelholm SA, Broholm H, Hansen Møller E, Klose M, Roed H, Juhler M.

Acta Oncol. 2017 Mar;56(3):415-421. doi: 10.1080/0284186X.2016.1270466. Epub 2017 Jan 13.

PMID:
28084862
15.

Progressive strength training to prevent LYmphoedema in the first year after breast CAncer - the LYCA feasibility study.

Ammitzbøll G, Lanng C, Kroman N, Zerahn B, Hyldegaard O, Kaae Andersen K, Johansen C, Dalton SO.

Acta Oncol. 2017 Feb;56(2):360-366. doi: 10.1080/0284186X.2016.1268266. Epub 2017 Jan 13.

PMID:
28084150
16.

Satisfaction with sex life in sexually active heterosexual couples dealing with breast cancer: a nationwide longitudinal study.

Rottmann N, Gilså Hansen D, dePont Christensen R, Hagedoorn M, Frisch M, Nicolaisen A, Kroman N, Flyger H, Johansen C.

Acta Oncol. 2017 Feb;56(2):212-219. doi: 10.1080/0284186X.2016.1266086. Epub 2017 Jan 12.

PMID:
28080186
17.

FAMily-Oriented Support (FAMOS): development and feasibility of a psychosocial intervention for families of childhood cancer survivors.

Salem H, Johansen C, Schmiegelow K, Winther JF, Wehner PS, Hasle H, Rosthøj S, Kazak AE, E Bidstrup P.

Acta Oncol. 2017 Feb;56(2):367-374. doi: 10.1080/0284186X.2016.1269194. Epub 2017 Jan 12.

PMID:
28080169
18.

The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.

Poulsen SH, Urup T, Grunnet K, Christensen IJ, Larsen VA, Jensen ML, Af Rosenschöld PM, Poulsen HS, Law I.

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):373-381. doi: 10.1007/s00259-016-3494-2. Epub 2016 Aug 23.

19.

Increased Intimal Hyperplasia After Vascular Injury in Male Androgen Receptor-Deficient Mice.

Wilhelmson AS, Fagman JB, Johansson I, Zou ZV, Andersson AG, Svedlund Eriksson E, Johansson ME, Lindahl P, Fogelstrand P, Tivesten Å.

Endocrinology. 2016 Oct;157(10):3915-3923. Epub 2016 Aug 17.

PMID:
27533884
20.

Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling.

Clausen BH, Degn M, Sivasaravanaparan M, Fogtmann T, Andersen MG, Trojanowsky MD, Gao H, Hvidsten S, Baun C, Deierborg T, Finsen B, Kristensen BW, Bak ST, Meyer M, Lee J, Nedospasov SA, Brambilla R, Lambertsen KL.

Sci Rep. 2016 Jul 7;6:29291. doi: 10.1038/srep29291.

Supplemental Content

Loading ...
Support Center